
Ironwood Capital
Description
Ironwood Capital is a Connecticut-based private equity firm specializing in providing non-control growth capital to established middle market businesses across the United States. Founded with a focus on supporting companies with proven business models, Ironwood Capital offers flexible capital solutions, primarily through subordinated debt, preferred stock, and minority equity investments. This approach allows them to partner with existing management teams, providing the necessary funding for expansion, acquisitions, or recapitalizations without seeking a controlling stake.
The firm targets companies demonstrating strong financial performance and significant growth potential. Specifically, Ironwood Capital looks to invest in businesses generating annual revenues between $20 million and $200 million, with an EBITDA ranging from $3 million to $20 million. Their typical investment size for a first cheque falls within the range of $10 million to $30 million per company. This substantial capital commitment is designed to fuel strategic initiatives and drive long-term value creation for their portfolio companies.
Ironwood Capital's investment philosophy centers on identifying resilient businesses with experienced management teams poised for the next phase of growth. They are sector-agnostic to a degree but have a strong track record across diverse industries, including manufacturing, business services, healthcare, consumer products, and distribution. By providing patient, non-dilutive capital, Ironwood Capital positions itself as a strategic partner, enabling companies to pursue their growth objectives while maintaining operational autonomy. Their focus on the middle market underscores their commitment to supporting the backbone of the American economy.
Investor Profile
Ironwood Capital has backed more than 34 startups, with 1 new investments in the last 12 months alone. The firm has led 7 rounds, about 21% of its total and boasts 12 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Private Equity, Seed, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
- Typical check size: $10M – $30M.
Stage Focus
- Private Equity (38%)
- Seed (15%)
- Series Unknown (12%)
- Series B (12%)
- Series A (9%)
- Series C (9%)
- Series D (6%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Manufacturing
- Software
- Medical Device
- Financial Services
- Fintech
- Information Technology
- Medical
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.